GFM
MENS

GF Fund Management’s Jyong Biotech MENS Stock Holding History

GF Fund Management’s Portfolio MENS Stock Details MENS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.23K Sell
1,559
-118
-7% -$250 ﹤0.01% 584
2026
Q1 		$3.61K Buy
1,677
+184
+12% +$450 ﹤0.01% 612
2025
Q4 		$5.9K Buy
+1,493
New +$52.7K ﹤0.01% 615

Other funds holding MENS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
SOW
State of Wyoming Cheyenne, Wyoming $989M AUM 52.24% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

GF Fund Management's MENS Position: Q2 2026 in Review

GF Fund Management reduced its Jyong Biotech (MENS) stake by 7% in Q2 2026, selling an estimated $250 and leaving 1,559 shares worth $3.23K. The position accounts for ﹤0.01% of the portfolio, ranked #584.

GF Fund Management first reported a position in MENS in Q4 2025 and has held it in 3 quarters since. The position peaked at $5.9K in Q4 2025. 19 funds tracked by Wall St. Rank hold MENS as of Q2 2026.

  • GF Fund Management held 1,559 shares of Jyong Biotech worth $3.23K as of Q2 2026.
  • GF Fund Management sold 118 Jyong Biotech shares in Q2 2026, an estimated $250.
  • Jyong Biotech made up ﹤0.01% of GF Fund Management's portfolio in Q2 2026, its #584 holding.
  • GF Fund Management first reported a position in Jyong Biotech in Q4 2025 and has held it in 3 quarters since.
  • GF Fund Management's Jyong Biotech position peaked at $5.9K in Q4 2025.
  • 19 funds tracked by Wall St. Rank held Jyong Biotech as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.